Total T2D at baseline, % (n) | 16.3 (358) | 9.5 (281) | 12.4 (639) | 100 |
Diagnosed at study entry, % (n) | 5.1 (113) | 2.8 (84) | 3.8 (197) | 31 |
With prevalent T2D at study entry, % (n) | 11.2 (245) | 6.7 (197) | 8.6 (442) | 69 |
Mean T2D duration, years (±SD) | | | 10.7 (±10.0) | |
Glucose-lowering treatment in prevalent T2D |
On special diet only, % (n) | 23.3 (57) | 34.5 (68) | | |
On diabetic medication, % (n) | 76.7 (188) | 65.5 (129) | | |
Using one drug, % (n) | 43.7 (107) | 40.1 (79) | | |
Using two drugs, % (n) | 25.7 (63) | 19.8 (39) | | |
Using three drugs, % (n) | 6.9 (17) | 4.6 (9) | | |
Using four drugs, % (n) | 0.4 (1) | 1.0 (2) | | |